ArticleEClinicalMedicine2025
AutoCOPD-A novel and practical machine learning model for COPD detection using whole-lung inspiratory quantitative CT measurements: a retrospective, multicenter study.
Article in EClinicalMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Geometric and quantum kernel methods for predicting skeletal muscle outcomes in experimental chronic obstructive pulmonary disease.Scientific reports · 2026Article
- AI enhancing differential diagnosis of acute chronic obstructive pulmonary disease and acute heart failure.iScience · 2026Article
- Nasal Microbiota Associated with the Lung Radiomic Features in Asthma.International journal of general medicine · 2026Article
- Factors Influencing Team-Based Vaccination Collaboration in Chronic Obstructive Pulmonary Disease: A Multicenter Cross-Sectional Survey of Primary Care Teams in Beijing, China.International journal of chronic obstructive pulmonary disease · 2026Article
- Evaluation of the impact of cardiopulmonary rehabilitation exercise training on cardiopulmonary function in patients with chronic obstructive pulmonary disease complicated by unstable angina pectoris using a hierarchical deep learning CT image model.Frontiers in physiology · 2026Article
- Advances in artificial intelligence applications for the management of chronic obstructive pulmonary disease.Frontiers in medicine · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
26 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: The rate of diagnosis for chronic obstructive pulmonary disease (COPD) is low worldwide. Quantitative computed tomography (QCT) parameters add value to quantify alterations in airway and lung parenchyma for COPD. This study aimed to assess the performance of QCT features in COPD detection using a whole-lung inspiratory CT model. Methods: This multicenter retrospective study was performed on 4106 participants. The derivation cohort containing 1950 participants who enrolled in Guangzhou communities from August 2017 to December 2019, was separated for training and internal validation cohorts, and three external validation cohorts containing 1703 participants were recruited from the public hospitals (Cohort 1: the First Affiliated Hospital of Guangzhou Medical University; Cohort 2: Xiangyang central hospital; Cohort 3: the Second Affiliated Hospital of Xi'an Jiaotong University) in China between April 2017 and May 2024. Questionnaire information, CT reports, and QCT features derived from inspiratory CT were extracted for model development. A novel multimodal framework using eXtreme gradient boosting and hybrid feature selection was established for COPD detection. National Lung Screening Trial (NLST) cohort (n = 453) was applied to validate the multiracial extrapolation and robustness on low-dose CT scans. Findings: The QCT model (referred to as AutoCOPD) with ten features achieved the highest AUC of 0·860 (95% CI: 0·823-0·898) in the internal validation cohort, and showed excellent discrimination when externally validated [Cohort 1: AUC = 0·915 (95% CI: 0·898-0·931); Cohort 2: AUC = 0·903 (95% CI: 0·864-0·943); Cohort 3: AUC = 0·914 (95% CI: 0·882-0·947); NLST: AUC = 0·881 (95% CI: 0·846-0·915)]. Decision curve analysis demonstrated that AutoCOPD was valuable across a range of COPD risk thresholds between 0·12 and 0·66 compared with intervention in all patients with COPD or no intervention. Interpretation: Heterogeneous COPD can be well identified using AutoCOPD (https://lwj-lab.shinyapps.io/autocopd/) constructed by a subset of only ten QCT features. It may be generalizable across clinical settings and serve as a feasible tool for early detecting patients with mild or asymptomatic COPD to reduce delayed diagnosis in routine practice. Funding: The National Natural Science Foundation of China, Guangzhou Laboratory, Natural Science Foundation of Guangdong Province, Guangzhou Municipal Science and Technology grant, State Key Laboratory of Respiratory Disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.